SCHEMBL7715013

SCHEMBL7715013

NC(=O)CNC1CCN(c2ccccc2CC(=O)O)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.44
MEN1 O00255 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
XBP1 P17861 1/20 0.44
CYP2C19 P33261 1/20 0.44
KMT2A Q03164 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
PDCD1 Q15116 1/20 0.44
CD274 Q9NZQ7 1/20 0.44
HRH1 P35367 1/20 0.43
CCR3 P51677 1/20 0.43
KCNH2 Q12809 1/20 0.43
KDM1A O60341 1/20 0.43
BRD4 O60885 1/20 0.39
TACR1 P25103 1/20 0.39
SIGMAR1 Q99720 4/20 0.39
FABP3 P05413 1/20 0.38
FABP4 P15090 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7715017 0.85 HRH1 (0.43) KDM4EMEN1CYP1A2CYP2D6CYP2C9
SCHEMBL7711167 0.81 NPC1 (0.56) KDM4EMEN1CYP1A2CYP2D6CYP2C9
SCHEMBL7715922 0.79 DRD4 (0.47) KDM4EMEN1CYP1A2CYP2D6CYP2C9
SCHEMBL7718924 0.78 TSHR (0.51)
SCHEMBL7719028 0.77 MYC (0.44) KDM4EMEN1CYP1A2CYP2D6CYP2C9
SCHEMBL7718948 0.77 NPY1R (0.49) KDM4EMEN1CYP1A2CYP2D6CYP2C9
SCHEMBL2553609 0.75 CKS1B (0.54) KMT2AHRH1CCR3KCNH2KDM1A
SCHEMBL8683997 0.75 FABP3 (0.55) KDM4EMEN1KMT2ANPSR1HRH1
SCHEMBL8005392 0.74 HRH1 (0.41) KDM4EMEN1KMT2AHRH1CCR3
SCHEMBL2555150 0.74 NOTUM (0.55) KDM4EMEN1CYP1A2CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6376503-B1 TREATMENT OF BENIGN PROSTATIC HYPERPLASIA MERCK & CO., INC 2002-04-23 US disclosed